Total Payments
$70,781
2024 Payments
$125.00
Companies
36
Transactions
520
Medicare Patients
4,646
Medicare Billing
$377,523
Payment Breakdown by Category
Other$57,335 (81.0%)
Food & Beverage$9,787 (13.8%)
Travel$3,605 (5.1%)
Education$53.59 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,335 | 24 | 81.0% |
| Food and Beverage | $9,787 | 456 | 13.8% |
| Travel and Lodging | $3,605 | 33 | 5.1% |
| Education | $53.59 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $49,448 | 100 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $13,681 | 19 | $0 (2022) |
| iRhythm Technologies, Inc. | $1,002 | 28 | $0 (2021) |
| Amgen Inc. | $832.73 | 47 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $690.47 | 50 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $624.72 | 38 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $588.65 | 47 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $479.32 | 25 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $355.27 | 28 | $0 (2021) |
| PORTOLA PHARMACEUTICALS, INC. | $353.05 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.00 | 1 | Amgen Inc. ($125.00) |
| 2022 | $638.63 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($638.63) |
| 2021 | $13,381 | 34 | Bayer HealthCare Pharmaceuticals Inc. ($12,839) |
| 2020 | $9,658 | 52 | Amarin Pharma Inc. ($9,067) |
| 2019 | $42,584 | 195 | Amarin Pharma Inc. ($40,197) |
| 2018 | $2,255 | 121 | Novartis Pharmaceuticals Corporation ($311.44) |
| 2017 | $2,140 | 115 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($214.01) |
All Payment Transactions
520 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 01/06/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $397.60 | General |
| Category: Cardio-renal | ||||||
| 01/06/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $241.03 | General |
| Category: Cardio-renal | ||||||
| 12/09/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: Cardio-renal | ||||||
| 12/03/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 11/15/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardio-renal | ||||||
| 10/14/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Cardio-renal | ||||||
| 10/08/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.35 | General |
| Category: Cardio-renal | ||||||
| 08/27/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Cardio-renal | ||||||
| 08/19/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,080.00 | General |
| Category: Cardio-renal | ||||||
| 07/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Cardiology | ||||||
| 06/24/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/17/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.10 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/15/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/14/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/10/2021 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/09/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.33 | General |
| 05/27/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Cardiovascular | ||||||
| 05/26/2021 | iRhythm Technologies, Inc. | ZIO Patch (Device) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/25/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/11/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Cardiology | ||||||
| 05/05/2021 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 19 | 1,527 | 2,137 | $360,822 | $127,748 |
| 2020 | 25 | 3,119 | 4,440 | $710,395 | $249,775 |
Total Patients
4,646
Total Services
6,577
Medicare Billing
$377,523
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 208 | 208 | $119,808 | $31,006 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 191 | 212 | $44,520 | $19,526 | 43.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 90 | 360 | $39,600 | $16,773 | 42.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2021 | 102 | 204 | $21,408 | $16,005 | 74.8% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 60 | 61 | $27,694 | $9,068 | 32.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 40 | 40 | $16,120 | $6,204 | 38.5% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 102 | 102 | $18,768 | $5,001 | 26.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 68 | 68 | $14,008 | $3,782 | 27.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 29 | 128 | $10,624 | $3,741 | 35.2% |
| 93458 | Insertion of catheter in left heart for imaging of blood vessels and left lower heart including imaging interpretation and supervision and injection | Facility | 2021 | 16 | 16 | $9,520 | $3,426 | 36.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 36 | $7,344 | $2,956 | 40.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 333 | 413 | $8,260 | $2,664 | 32.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $6,352 | $2,547 | 40.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 37 | $5,217 | $2,114 | 40.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 119 | 125 | $5,750 | $1,401 | 24.4% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2021 | 40 | 40 | $2,160 | $762.25 | 35.3% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2021 | 25 | 26 | $806.00 | $282.10 | 35.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2021 | 13 | 13 | $663.00 | $240.33 | 36.2% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2021 | 19 | 20 | $2,140 | $199.60 | 9.3% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2021 | 12 | 12 | $60.00 | $48.00 | 80.0% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 328 | 342 | $196,992 | $52,630 | 26.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 374 | 505 | $106,050 | $37,361 | 35.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2020 | 167 | 676 | $74,360 | $30,875 | 41.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2020 | 189 | 386 | $40,144 | $29,982 | 74.7% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 104 | 109 | $49,486 | $16,104 | 32.5% |
About Dr. Thomas Martyak, MD
Dr. Thomas Martyak, MD is a Interventional Cardiology healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285621003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Martyak, MD has received a total of $70,781 in payments from pharmaceutical and medical device companies, with $125.00 received in 2024. These payments were reported across 520 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($57,335).
As a Medicare-enrolled provider, Martyak has provided services to 4,646 Medicare beneficiaries, totaling 6,577 services with total Medicare billing of $377,523. Data is available for 2 years (2020–2021), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Fredericksburg, VA
- Active Since 10/06/2005
- Last Updated 10/20/2015
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1285621003
Products in Payments
- Vascepa (Drug) $49,448
- Kerendia (Drug) $13,477
- ZIO Patch (Device) $1,002
- ENTRESTO (Drug) $588.65
- Corlanor (Drug) $549.52
- BRILINTA (Drug) $500.15
- LifeVest (Device) $479.32
- MULTAQ (Drug) $442.21
- XARELTO (Drug) $355.27
- Repatha (Biological) $273.21
- PRALUENT (Drug) $248.26
- ANDEXXA (Drug) $227.29
- Adempas (Drug) $203.53
- PRALUENT ALIROCUMAB INJECTION (Biological) $194.51
- LEXISCAN (Drug) $179.62
- KENGREAL (Drug) $163.19
- PRADAXA (Drug) $162.86
- Livalo (Drug) $152.25
- ELIQUIS (Drug) $142.72
- BYSTOLIC (Drug) $138.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Fredericksburg
Dr. Rajiv Tayal, M.d., M.p.h, M.D., M.P.H
Interventional Cardiology — Payments: $980,411
Interventional Cardiology $980,411
Zeshan Rana, M.d, M.D
Interventional Cardiology — Payments: $28,759
Interventional Cardiology $28,759
Ashok Prasad, M.d, M.D
Interventional Cardiology — Payments: $11,174
Interventional Cardiology $11,174
Thomas Wheeler, Md, MD
Interventional Cardiology — Payments: $4,511
Interventional Cardiology $4,511
Dr. Gregory Pellizzon, M.d, M.D
Interventional Cardiology — Payments: $1,403
Interventional Cardiology $1,403
Scott Seidner, M.d, M.D
Interventional Cardiology — Payments: $281.44
Interventional Cardiology $281.44